share_log

Stephens & Co. Initiates Coverage On C4 Therapeutics With Equal-Weight Rating, Announces Price Target of $4

Stephens & Co. Initiates Coverage On C4 Therapeutics With Equal-Weight Rating, Announces Price Target of $4

史蒂芬斯公司開始對c4 therapeutics進行覆蓋,給予等權重評級,宣佈目標價爲$4
Benzinga ·  11/18 23:24  · 評級/大行評級

Stephens & Co. analyst Sudan Loganathan initiates coverage on C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight rating and announces Price Target of $4.

Stephens & Co. 分析師蘇丹·洛根納坦對c4 therapeutics(納斯達克:CCCC)啓動了覆蓋,給予了相等權重評級,並宣佈目標價格爲4美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論